No intervention
OtherThis is a non-interventional study.
NCT Number: NCT06843226
The main aim of this study is to collect more information on the effectiveness of TDV when used in a pilot public vaccination program for children and adolescents participating in a community-based cohort in Southeast Asian countries with high dengue transmission, specifically Thailand, Indonesia, and Malaysia where TDV is already approved for use.
The study will include cohort participants (individual follow-up of 3 years) who may or may not later be vaccinated with TDV as part of a pilot public vaccination program in the study countries. The study will investigate if cohort participants who were vaccinated with TDV have less hospital stays due to dengue than cohort participants who were not vaccinated with TDV. The study will also provide further information on the effectiveness of TDV against the least common dengue virus serotypes (DENV-3 and DENV-4).
Interested in participating?
Request Info6 year–12 year
All sexes
Observational
Fakultas Kedokteran Lambung Mangkurat, Banjarmasin, South Kalimantan, Indonesia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cohort:
To be eligible for inclusion in the study cohort, participants must meet the following inclusion criteria:
Cases:
To be eligible for inclusion as a case, participants must meet the following inclusion criteria:
Controls:
To be eligible for inclusion as a matched control, participants must meet the following inclusion criteria:
Exclusion criteria
Cases:
To be eligible for inclusion as a case participants must not meet any of the following criteria:
Controls:
To be eligible for inclusion as a control participants must not meet any of the following criteria:
This is a non-interventional study.
Time frame: Up to Month 36
Number of participants hospitalized due to VCD of any dengue serotype in unvaccinated and fully vaccinated participants.
Time frame: Up to Month 36
Number of participants hospitalized due to VCD with each infecting dengue serotype (dengue virus [DENV]-1, DENV-2, DENV-3, and DENV-4) in unvaccinated and fully vaccinated participants will be reported.
Time frame: Up to Month 36
Number of participants hospitalized due to VCD with dengue serostatus (seronegative and seropositive) of any dengue serotype in unvaccinated and fully vaccinated participants will be reported.
Time frame: Up to Month 36
Number of participants hospitalized due to VCD by each infecting dengue serotype and baseline dengue serostatus (DENV-1 in baseline seronegative, DENV-2 in baseline seronegative, DENV-3 in baseline seronegative, DENV-4 in baseline seronegative, DENV-1 in baseline seropositive, DENV-2 in baseline seropositive, DENV-3 in baseline seropositive, and DENV-4 in baseline seropositive) in unvaccinated and fully vaccinated participants will be reported.
Contact information is provided by the study sponsor or research team.
Takeda
Industry
The Association Between Prior Exposure to Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and Dengue Hospitalization in a Pediatric and Adolescent Population: A Nested Case-Control Post-Authorization Effectiveness Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06665035
Arbovirus Infections, Dengue
Barranquilla, Atlántico, Colombia
View Trial DetailsNCT06579755
Arbovirus Infections, Dengue
Buenos Aires, Argentina
View Trial DetailsNCT07409857
Arbovirus Infections, Dengue
Bangkok, Thailand
View Trial DetailsNCT07007585
Arbovirus Infections, Blood Platelet Disorders
Piedras Negras, Coahuila, Mexico
View Trial Details